Experimental combo for recurrent prostate cancer halted early
NCT ID NCT03553602
First seen Jan 31, 2026 · Last updated May 18, 2026 · Updated 11 times
Summary
This study looked at a treatment for prostate cancer that came back after earlier radiation therapy. The approach combined temporary radioactive implants placed in the prostate, external radiation to the pelvis, and 6 months of hormone therapy. The goal was to check safety and whether the cancer could be controlled. Only 3 people took part before the study was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER RECURRENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Loyola University Medical Center
Maywood, Illinois, 60153, United States
Conditions
Explore the condition pages connected to this study.